Pharmaceuticals

Cardiac Biomarkers Testing Market Outlook Highlighting Key Drivers And Market Evolution

April 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Cardiac Biomarkers Testing Market In 2026 And 2030?

The cardiac biomarkers testing market has exhibited substantial growth in recent years. This market is projected to expand from $14.95 billion in 2025 to $16.7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.7%. The historical expansion can be attributed to a rising incidence of cardiovascular diseases, increasing awareness about cardiac health, advancements in laboratory diagnostics, growing hospital infrastructure, and increasing government healthcare initiatives.

The cardiac biomarkers testing market size is projected to witness substantial growth in the upcoming years. It is forecast to expand to $25.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.6%. The expansion during this period stems from factors including the integration of AI in diagnostics, the proliferation of home-based and remote monitoring, the evolution of precision medicine, the creation of multi-biomarker panels, and the increasing requirement for real-time cardiac monitoring. Significant trends expected in the forecast period encompass the embrace of point-of-care testing, the development of miniaturized and portable diagnostic devices, innovations in biomarker multiplexing technologies, the practice of personalized cardiac risk profiling, and the seamless integration of wearables for cardiac monitoring.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp

What Leading Drivers Are Supporting The Cardiac Biomarkers Testing Market Expansion?

The rising occurrence of cardiovascular diseases is anticipated to stimulate the growth of the cardiac biomarkers testing market moving forward. Cardiovascular disease describes medical conditions affecting the heart or blood vessels. Cardiac biomarker tests help identify biomarker levels to promptly assess the severity and scale of a heart attack. Therefore, more cases of cardiovascular diseases will boost the demand for cardiac biomarker testing solutions. As an illustration, in January 2024, data from the American Heart Association, a US-based non-profit organization, indicated that the age-adjusted death rate from cardiovascular disease climbed to 233.3 per 100,000 in 2024, an increase of 4.0% from 224.4 per 100,000 in 2023. Consequently, the increasing prevalence of cardiovascular diseases is fueling the expansion of the cardiac biomarkers testing market.

How Is The Cardiac Biomarkers Testing Market Organized By Segment Classification?

The cardiac biomarkers testing market covered in this report is segmented –

1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types

2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications

3) By End-User: Hospitals, Specialty Clinics

What Emerging Trends Are Seen In The Cardiac Biomarkers Testing Market?

Major companies operating within the cardiac biomarker testing market are forming strategic alliances to deliver technology aimed at detecting early indicators of heart conditions and improving patient results. These strategic partnerships in cardiac biomarker testing foster collaboration between entities, enabling the development of groundbreaking diagnostics, expanding market reach, and accelerating the deployment of advanced testing solutions for better cardiovascular care. For instance, in September 2024, MediBuddy, an Indian healthcare technology company providing a comprehensive platform for telehealth services, health management, and insurance assistance, entered into a partnership with Philips, a Netherlands-based conglomerate corporation. Through this collaboration, they intend to elevate cardiac care in India by integrating Philips’ HeartPrint technology, which facilitates regular monitoring and risk assessment of heart health. This forward-looking approach empowers users with sophisticated tools on the MediBuddy platform, encouraging proactive management of heart health and superior outcomes.

Who Are The Industry Participants Involved In The Cardiac Biomarkers Testing Market?

Major companies operating in the cardiac biomarkers testing market are Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation

Get The Full Cardiac Biomarkers Testing Market Report:

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Where Is The Cardiac Biomarkers Testing Market Primarily Concentrated By Region?

North America was the largest region in the cardiac biomarkers testing market in 2025. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cardiac Biomarkers Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Browse Through More Reports Similar to the Global Cardiac Biomarkers Testing Market 2026, By The Business Research Company

Cardiac Biomarkers Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Cardiac Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

Clinical Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795